Check out our most popular compounded medications! Get Started
Budesonide 5 mg Slow Release Acid Resistant Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. These capsules are used to treat conditions such as Asthma, Crohn's Disease, Ulcerative Colitis, Allergic Rhinitis, and Eosinophilic Esophagitis. Their acid-resistant feature ensures the medication is not affected by stomach acid.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Budesonide 5 mg Slow Release Acid Resistant Capsules are a specialized medication designed to treat a range of respiratory conditions, including asthma, Chronic Obstructive Pulmonary Disease (COPD), rhinitis, bronchitis, and allergic rhinitis. This unique formulation is engineered to provide a slow, sustained release of the active ingredient, Budesonide, a potent corticosteroid known for its anti-inflammatory properties.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology ensures the gradual release of the encapsulated medication over an extended period, offering sustained therapeutic effects. This slow-release mechanism not only enhances the efficacy of the medication but also reduces the dosing frequency, thereby improving patient compliance, particularly for those requiring a controlled and prolonged release profile.
The acid-resistant feature of the capsules ensures that the medication is released in the small intestine, optimizing absorption and effectiveness. Budesonide works by reducing inflammation in the airways, alleviating symptoms such as wheezing, coughing, and difficulty breathing. It can also help to reduce the frequency and severity of asthma attacks and COPD exacerbations. For patients with rhinitis, bronchitis, and allergic rhinitis, it can help to alleviate nasal congestion, sneezing, and other symptoms.
This formulation of Budesonide is a comprehensive treatment solution for a variety of respiratory conditions. It is crucial to adhere to your healthcare provider's instructions when taking this medication. If you have any queries about this formulation or how it can help manage your condition, please do not hesitate to contact us at Bayview Pharmacy.
This formulation of Budesonide 5 mg Slow Release Acid Resistant Capsules is specifically designed for the treatment of various respiratory conditions such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Bronchitis, and Allergic Rhinitis. Budesonide, the active ingredient, is a potent corticosteroid that functions by reducing inflammation in the airways. This action helps to alleviate symptoms such as wheezing, coughing, and difficulty breathing.
It is crucial to understand that Budesonide is not a rescue medication and should not be used to treat sudden asthma attacks. Instead, it is used as a maintenance treatment for Asthma, aiming to reduce the frequency and severity of asthma attacks. In the case of COPD, Budesonide is employed to decrease the frequency and severity of exacerbations.
For Rhinitis, Bronchitis, and Allergic Rhinitis, Budesonide works to reduce inflammation and symptoms such as nasal congestion, runny nose, and sneezing. The medication should be taken as directed by your healthcare provider. Regular intake of Budesonide is essential to derive the maximum benefit from it.
This formulation is compounded with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
If you have any questions about this formulation or how it can help manage your condition, please consult with your healthcare provider. They can provide you with the most accurate and personalized advice based on your specific health needs and circumstances.
Budesonide 5 mg Slow Release Acid Resistant Capsules are a specialized medication designed to treat a range of respiratory conditions, including asthma, COPD, rhinitis, bronchitis, and allergic rhinitis. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism provides sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The acid-resistant feature of the capsules safeguards the medication from premature breakdown in the stomach, ensuring it is effectively absorbed in the small intestine. This results in a more consistent and sustained release of the active ingredient, Budesonide, into the body.
In the treatment of asthma, this formulation works to reduce inflammation in the airways, facilitating improved airflow and alleviating symptoms. It also aids in decreasing the frequency of asthma attacks. For patients with COPD, this formulation assists in reducing inflammation and mucus production, leading to improved airflow and symptom relief. Similarly, for conditions such as rhinitis, bronchitis, and allergic rhinitis, this formulation works to reduce inflammation and mucus production, resulting in improved airflow and symptom relief.
If you have any queries about this formulation or its potential benefits in treating these respiratory conditions, please do not hesitate to contact us. We are committed to assisting you in finding the most suitable treatment option tailored to your individual needs.
Budesonide 5 mg Slow Release Acid Resistant Capsules are a versatile medication, formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects and improved patient compliance due to reduced dosing frequency. These capsules can be used to treat a wide range of conditions.
For patients with Chronic Obstructive Pulmonary Disease (COPD), these capsules can help reduce inflammation in the airways, improving breathing and overall quality of life.
Budesonide 5 mg Slow Release Acid Resistant Capsules may also be used in the treatment of certain types of cancer, including lymphoma and leukemia, by helping to control the growth and spread of cancer cells. In the realm of autoimmune diseases, these capsules can be beneficial for conditions such as rheumatoid arthritis and lupus, helping to manage inflammation and reduce symptoms.
For patients with gout, these capsules can help reduce inflammation in the joints, providing relief from pain and swelling. They may also be used to treat certain types of skin conditions, such as psoriasis and eczema, by reducing inflammation and helping to slow the rapid overgrowth of skin cells that leads to scaling and redness.
If you have any questions about the use of Budesonide 5 mg Slow Release Acid Resistant Capsules for any of these conditions, please do not hesitate to reach out for more information.
Budesonide 5 mg Slow Release Acid Resistant Capsules are a type of medication that is designed to release the active ingredient, Budesonide, gradually over an extended period of time. This is achieved through the use of a controlled-release polymer known as Methocel E4M.
Methocel E4M is a type of controlled-release polymer that is used in the formulation of these capsules. It is designed to release the encapsulated medication gradually over an extended period of time, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Due to the slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific medical condition and response to therapy.
'Acid resistant' means that the capsules are designed to withstand the acidic environment of the stomach. This ensures that the medication is not released until it reaches the part of the gastrointestinal tract where it is intended to act.
As with any medication, Budesonide 5 mg Slow Release Acid Resistant Capsules may have potential side effects. It is important to discuss these with your healthcare provider before starting the medication.
Not everyone can take Budesonide 5 mg Slow Release Acid Resistant Capsules. It is important to discuss your medical history with your healthcare provider before starting this medication. They will be able to determine if this medication is suitable for you.
It is important to discuss all medications you are currently taking with your healthcare provider before starting Budesonide 5 mg Slow Release Acid Resistant Capsules. They will be able to determine if there are any potential interactions.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Store Budesonide 5 mg Slow Release Acid Resistant Capsules at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
